CRT 2025

Late-Breaking Clinical Trials Structural

Outcomes of Single Antiplatelet, Dual Antiplatelet, or Oral Anticoagulation After Amulet | Insights from the EMERGE LAA Post-Approval Study

Speaker(s)

• 

  Atman P. Shah, MD

  Co-Director, Cardiac Catheterization Laboratory
  University of Chicago
  Chicago, Illinois, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)